The Journal of Immunology, Vol 141, Issue 5 1495-1501, Copyright © 1988 by American Association of Immunologists

ARTICLES

Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus

XP Liang, ME Lamm and JG Nedrud
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.

Successful oral immunization to prevent infectious diseases in the gastrointestinal tract as well as distant mucosal tissues may depend on the effectiveness of an Ag to induce gut immune responses. We and others have previously reported that cholera toxin possesses strong adjuvant effects on the gut immune response to co-administered Ag. To explore further adjuvant effects of cholera toxin, the holotoxin or its B subunit was chemically cross-linked to Sendai virus. The resulting conjugates, which were not infectious, were evaluated for their capacity to induce gut immune responses against Sendai virus after oral administration to mice. Conjugating cholera toxin to virus significantly enhanced the adjuvant activity of cholera toxin compared to simple mixing. Cholera toxin B subunit, however, did not show an adjuvant effect either by itself or conjugated with the virus. Oral administration of the Sendai virus-cholera toxin conjugate was also able to prime for protective anti-viral responses in the respiratory tract. Mice that were orally immunized with the conjugate and intra- nasally boosted with inactivated virus alone showed virus-specific IgA titers in nasal secretions that correlated with protection against direct nasal challenge with live Sendai virus. For comparison, s.c. immunization was also studied. Systemic immunization with the virus- cholera toxin conjugate induced virus-specific antibody responses in serum as well as in the respiratory tract but failed to protect the upper respiratory tract against virus challenge. Systemic immunization plus an intra-nasal boost did, however, confer a variable degree of protection to the upper respiratory tract, which correlated primarily with bronchoalveolar lavage (lung) antibody titers.

This article has been cited by other articles:

				W. Kang and K. A. Kudsk Is There Evidence That the Gut Contributes to Mucosal Immunity in Humans? JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 246 - 258. [Abstract] [Full Text] [PDF]

				L. Yuan, C. Iosef, M. S. P. Azevedo, Y. Kim, Y. Qian, A. Geyer, T. V. Nguyen, K.-O. Chang, and L. J. Saif Protective Immunity and Antibody-Secreting Cell Responses Elicited by Combined Oral Attenuated Wa Human Rotavirus and Intranasal Wa 2/6-VLPs with Mutant Escherichia coli Heat-Labile Toxin in Gnotobiotic Pigs J. Virol., October 1, 2001; 75(19): 9229 - 9238. [Abstract] [Full Text] [PDF]

				R. Weltzin, B. Guy, W. D. Thomas Jr., P. J. Giannasca, and T. P. Monath Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection Infect. Immun., May 1, 2000; 68(5): 2775 - 2782. [Abstract] [Full Text] [PDF]

				M. P. Matousek, J. G. Nedrud, W. Cieplak Jr., and C. V. Harding Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit Infect. Immun., July 1, 1998; 66(7): 3480 - 3484. [Abstract] [Full Text] [PDF]

				D. Grdic, E. Hornquist, M. Kjerrulf, and N. Y. Lycke Lack of Local Suppression in Orally Tolerant CD8-Deficient Mice Reveals a Critical Regulatory Role of CD8+ T Cells in the Normal Gut Mucosa J. Immunol., January 15, 1998; 160(2): 754 - 762. [Abstract] [Full Text] [PDF]